WFDC2 and peritoneum cancer: Mi’s research indicates that serum HE4 levels can contribute to diagnosing, evaluating treatment responses, and predicting recurrence in patients with advanced ovarian cancer, fallopian tube cancer, and peritoneal cancer (38).